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Background: Primary biliary cirrhosis (PBC) is an autoimmune liver disease targeting the intrahepatic small
bile ducts showing chronic non-suppurative destructive cholangitis (CNSDC). Recent studies suggest that
naturally-occurring CD4+CD25high regulatory T cells (Tregs) expressing Forkhead box P3 (Foxp3) play an
active role in immunological self-tolerance.
Aims: To investigate whether Foxp3+Tregs are involved in the pathogenesis of PBC.
Methods: Foxp3+Tregs was detected immunohistochemically in livers from patients with PBC (n = 27), chronic
viral hepatitis (CVH) (n = 15), and normal subjects (n = 10). The distribution of Tregs in portal tracts was semi-
quantitatively evaluated in each groups. Levels of Foxp3, IL-10, TGFb, IFNc and TNFa mRNA was evaluated
in PBC (n = 15) and control livers (n = 21) using semi-quantitative reverse transcriptase-PCR.
Results: In PBC and CVH livers, the amounts of infiltrating Foxp3+Tregs in portal tracts were in parallel with
the degree of portal inflammation irrespective of disease. The infiltration of Foxp3+Tregs into portal tracts with
CNSDC in PBC was foremost in comparison with inflamed portal tracts in CVH or those without CNSDC in
PBC (p,0.05). Focally, Tregs infiltrated into the biliary epithelial layer at the site of CNSDC. The level of
Foxp3, IL-10 and TGFb mRNA expression was high in PBC compared with normal livers (p,0.05). IFNc and
TNFa mRNA was high in early PBC and CVH livers.
Conclusion: Results of this evaluation of Foxp3+Tregs do not suggest that the reduced regulatory function
accounts for the development of CNSDC in PBC.
P
rimary biliary cirrhosis (PBC) is an organ specific
autoimmune disease and is histologically characterised as
a cholangitis of small bile ducts (chronic non-suppurative
destructive cholangitis; CNSDC) eventually followed by their
extensive loss from the liver.1–4 This is supported by the
presence of anti-mitochondrial antibodies and autoreactive T
and B cells, in conjunction with frequent association with other
autoimmune disease.5–7 Recent data suggest that autoreactive T
cell response plays a major role in the pathophysiology of bile
duct lesions in PBC.7 8 In particular, loss of tolerance to self
antigen, particularly pyruvate dehydrogenase E2 component
related to or located in the small bile ducts may be a central
event in CNSDC in PBC.
Recently, accumulating data suggest that naturally-occurring
CD4+CD25high regulatory T cells (Tregs) play an active part in
establishing and maintaining immunological self-tolerance and
also have a role in negative control of various immune
responses to non-self antigens.9–11 The disturbance of Tregs
may be responsible for the development and progression of
several autoimmune diseases.12–15 Most of the known surface
markers of these Tregs, including CD25, are also up-regulated
in activated conventional CD4+CD25high T cells without
regulatory function.9–11 Recently, Forkhead box P3 (Foxp3)
has been reported as one of the best markers of naturally-
occurring Tregs, and Foxp3 is crucially related to the develop-
ment and function of Tregs.9–11 16 There have been few reports
regarding the significance of Foxp3+Tregs in PBC, so far.17–19
Lan et al recently reported the relative decrease of Foxp3+Tregs
in PBC and suggested that Foxp3+Tregs may play a role in the
loss of tolerance in PBC,17 although their results have not been
confirmed by other groups.
In order to clarify the significance of naturally occurring
Tregs in the pathogenesis of the bile duct lesion of PBC, we
investigated the distribution of Foxp3+Tregs in liver tissues of
PBC patients and controls with reference to histopathological
findings of portal tracts and cholangiopathy. Furthermore, we
examined the level of mRNA expression of Foxp3, interleukin-
10 (IL-10) and transforming growth factor (TGF) b (immuno-
suppressive cytokines secreted by Tregs),11 interferon (IFN) c (a
hallmark cytokine of T helper 1 (Th1) immune response) and
tumour necrosis factor (TNF) a (proinflammatory cytokine) in
PBC and control livers. IFNc and TNFa are reportedly up-
regulated and involved in the pathophysiology of PBC.20–23
MATERIALS AND METHODS
Patients
A total of 52 liver tissue specimens (all were wedge biopsied or
surgically-resected) were collected from the liver disease file of
our laboratory and affiliated hospitals. This is a retrospective
study and when possible, the frozen tissues for mRNA
evaluation were obtained. There was no difference in the
clinical background between the patient groups with and
without frozen tissue. To obtain enough number of portal tracts
(at least 5) for evaluation, we used only wedge or excision
tissues. There were no selection criteria for the patients group of
wedge biopsy and those of needle biopsy. The liver specimens
consisted of 27 PBC, 15 chronic viral hepatitis (CVH) livers and
10 ‘‘histologically normal’’ livers. All PBC were from patients
fulfilling the clinical, serological and histological characteristics
consistent with the diagnosis of PBC.3 PBC livers were staged
Abbreviations: CNSDC, chronic non-suppurative destructive cholangitis;
CVH, chronic viral hepatitis; Foxp3, Forkhead box P3; IL, interleukin; IFN,
interferon; PBC, primary biliary cirrhosis; RT, reverse transcriptase; TGF,
transforming growth factor; Th, T helper; TNF, tumour necrosis factor;
Tregs, regulatory T cells
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histologically (stages 1/2, n = 17; stages 3/4, n = 10).3 24 Eight
and seven CVH were regarded as F0–2 and F3/4, respectively.25
Three and 12 CVH cases were serologically positive for hepatitis
B surface B antigen and anti-hepatitis C viral antibody,
respectively. None of the patients received treatment with
ursodeoxycholic acid and interferon before histological diag-
nosis. ‘‘Histologically normal’’ livers were obtained from
surgically resected livers for traumatic hepatic rupture or
metastatic liver tumour.
Preparation of liver tissues
Liver tissue samples were fixed in 10% neutral buffered
formalin, and embedded in paraffin. More than 20 serial
sections, 4 mm thick, were cut from each block. Several were
processed routinely and the remainder were processed for the
following immunohistochemistry. For the analysis of mRNA
expression, frozen liver tissue specimens from the patients with
PBC (n = 15) (stages 1/2, n = 8; stages 3/4, n = 7), CVH (n = 9)
(F1/2, n = 2; F3/4, n = 7) and ‘‘histologically normal’’ livers
(n = 12) were used.
Classification of intrahepatic biliary tree
The intrahepatic biliary tree is classified into the intrahepatic
large and small bile ducts by their size and distribution in the
portal tracts.4 26 Septal and interlobular bile ducts are collec-
tively termed small bile ducts. Bile ductules were evaluated
separately and not included in the small bile ducts. In this
study, the small bile ducts were mainly examined.
Types of portal tract histopathology
Portal tracts in the liver specimens were largely classified into
three types: A, inflamed portal tracts containing CNSDC; B,
chronically inflamed portal tracts without CNSDC; and C, non-
inflamed portal tracts.
Immunohistochemistry
Foxp3 was detected using mouse monoclonal anti-Foxp3
(Abcam, Cambridge, UK) and Envision+ solution (Dako,
Glostrup, Denmark) as described previously.27 Deparaffinised
sections were pretreated in a microwave oven in EDTA buffer
(pH 9) at 95 C˚ for 20 min. A similar dilution of the control
mouse IgG (Dako) was applied instead of the primary antibody
as negative control. Foxp3 is detected in the nuclei of round
cells regarded as naturally-occurring Tregs, when present. Since
the monoclonal antibody we used in this study was raised
against the C-terminus residues (400–431) of Foxp3, it reacts
with both ‘‘normal’’ Foxp3 and its splice variant that lacks
exon2 (residues 72–106).28 29 Foxp3 is preferentially expressed
by CD4+CD25+Tregs30 and human Tregs reportedly coexpress
equal amounts of two isoforms of Foxp3.28 Although CD8+T
cells as well as CD8+/CD28 suppressor cells are reported to
express the spliced variants of Foxp3,29 most Foxp3+ cells were
CD4-positive and there was no CD8+ Foxp3+ cell in our
preliminary study (data not shown).
Semiquantitative analysis of Foxp3-expressing
inflammatory cells
The extent of infiltration of Foxp3-expressing cells in individual
portal tracts was graded as follows: 0, portal tract containing
,2 Foxp3-expressing cells; 1, portal tract containing 2–5
Foxp3-expressing cells; 2, portal tract containing 6–10 Foxp3-
expressing cells; and 3, portal tract containing .10 Foxp3-
expressing cells.
Extraction of RNA and semi-quantitative reverse-
transcriptase (RT)-PCR
Total RNA was extracted from the liver tissues or cells with a
QIAGEN RNeasy Mini kit (QIAGEN, Hilden, Germany)
according to the recommendations of the manufacturer. After
cDNA was synthesised, semi-quantitative RT-PCR was carried
out as described previously.31 Table 1 shows primers used for
RT-PCR. Gel images were evaluated using NIH image and the
expression was normalised as a ratio using human G3PDH as a
housekeeping gene. Data were expressed as mean (SD).
Statistical analysis
Statistical analysis for the differences in the human study used
the Wilcoxon rank sum test. Statistical analysis of the
differences in the in vitro assays used Student’s t test. The
difference was considered as significant when p,0.05.
RESULTS
Distribution of Foxp3+Tregs in PBC and control l ivers
The amounts of Foxp3+Tregs infiltrated in portal tracts were
graded according to individual types of portal tracts in PBC and
control livers (fig 1).
Normal and CVH livers
There were few Foxp3+Tregs in portal tracts and in hepatic
parenchyma in normal livers (fig 2A). Foxp3+Tregs infiltrated
mainly in portal tracts in CVH livers; the extent of Foxp3+Tregs
infiltration was in parallel with the extent of chronic
inflammation (fig 1). Foxp3+Tregs was scattered around
follicle-like accumulation of lymphoid cells in CVH livers
(fig 2B).
PBC livers
Foxp3+Tregs infiltrated mainly in portal tracts (fig 2C,D); the
number of Foxp3+Tregs was negligible in hepatic parenchyma.
The extent of Foxp3+Tregs infiltration was in parallel with the
extent of chronic inflammation as seen in CVH livers (fig 1).
Foxp3+Tregs infiltrated more extensively into portal tracts with
Table 1 Primers for RT-PCR
Gene Genbank no Forward primer (59 to 39) Reverse primer (59 to 39) Product size
Foxp3 NM014009 TCATCCGCTGGGCCATCCTG GTGGAAACCTCACTTCTTGGTC 385bp
IL-10 NM000572.2 ATGCCCCAAGCTGAGAACCAAGACCCA TCTCAAGGGGCTGGGTCAGCTATCCCA 352bp
TGFb NM000660.3 CAGAAATACAGCAACAATTCCTGG TTGCAGTGTGTTATCCCTGCTGTC 190bp
TNFa NM000594.2 GAGTGACAAGCCTGTAGCCCATGTTGTAGCAT GCAATGATCCCAAAGTAGACCTGCCCAGACT 444bp
IFNc NM000619.2 GCATCGTTTTGGGTTCTCTTGGCTCTTACTGC CTCCTTTTTCGCTTCCCCTGTTTTAGCTGCTGG 427bp
G3PDH BC023632 GAACGGGAAGCTCACTGGCATGGC TGAGGTCCACCACCCTGTTGCTG 311bp
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CNSDC in PBC, when compared with those without CNSDC in
PBC and CVH (p,0.05) (fig 1). Foxp3+Tregs infiltrated
occasionally into the biliary epithelial layer at the site of
CNSDC (fig 2C,D). The extent of Foxp3+Tregs in inflamed
portal tracts with CNSDC in early stage of PBC was higher than
in late stage of PBC.
Increased mRNA expression of Foxp3, IL-10 and TGFb in
PBC livers
Figure 3A shows the representative gel image and the semi-
quantitative levels of Foxp3, IL-10 and TGFb in PBC and control
livers.
Foxp3
The level of Foxp3 mRNA expression was high in PBC livers
compared with normal livers (p,0.05) (fig 3B). Although
Foxp3 mRNA expression tended to be higher in CVH livers
compared to normal livers, there was no significant difference.
IL-10
The level of Il-10 mRNA expression was high in the early stage
of PBC livers compared with normal livers and CVH livers
(p,0.05) (fig 3C). In advanced stage PBC, the level of Il-10
mRNA expression was high compared to normal livers
(p,0.05).
TGFb
The level of TGFb mRNA expression was high in the early stage
of PBC livers compared with normal livers (p,0.05) (fig 3D).
Although TGFb mRNA expression tended to be higher in
advanced stage PBC and CVH livers compared to normal livers,
there was no significant difference.
Increased mRNA expression of IFNc and TNFa and the
ratio of IFNc/Foxp3 in PBC livers
Figure 4 shows the semi-quantitative level of IFNc and TNFa
mRNA expression and the ratios of IFNc/Foxp3 and TNFa/
Foxp3 in PBC and control livers.
IFNc
The level of IFNc mRNA expression was high in the early stage
of PBC and CVH livers compared with normal livers (p,0.05)
(fig 4A). The ratio of IFNc/Foxp3 was significantly high in the
early stage of PBC and CVH livers compared with normal livers
(p,0.05) (fig 4B).
TNFa
The level of TNFa mRNA expression tends to be high in PBC
and CVH livers and a significant difference was seen between
the early stage of PBC and normal livers (p,0.05) (fig 4C). The
ratio of TNFa/Foxp3 was significantly high in CVH livers
compared with normal livers (p,0.05) (fig 4D).
DISCUSSION
We have investigated the distribution of Foxp3+Tregs and the
level of mRNA expression of Foxp3 and related cytokines in
PBC and control livers to clarify the significance of Foxp3+Tregs
in the pathogenesis of PBC. We thought that the loss of self-
tolerance in the small bile ducts might cause CNSDC in PBC,
and that the number of Tregs in portal tracts, particularly those
with CNSDC might be reduced. However, we failed to find a
decrease of Foxp3+Tregs reflecting sustained tolerance to self-
antigen in the present study. Foxp3+Tregs infiltration was in
parallel with the extent of chronic inflammation in portal tracts
in both PBC and CVH livers. It was of interest that the extent of
Foxp3+Tregs infiltration was rather high in portal tracts with
CNSDC. There was a difference between early stage PBC and
late stage PBC livers in the extent of Foxp3+Tregs infiltration in
inflamed portal tract with CNSDC.
Furthermore, the level of Foxp3, IL-10 and TGFb mRNA
expression was higher in PBC than normal livers and the level
of IL-10 mRNA expression was significantly higher in early
stage PBC, when compared with CVH. The level of IFNc and
TNFa was also high in early stage PBC and CVH livers. These
data also support the rather high extent of Foxp3+Tregs
infiltration in parallel with the extent of chronic inflammation
detected by immunohistochemical study. It is of interest that
the ratio of IFNc/Foxp3 tends to be high in the early stage of
PBC compared to the advanced stage of PBC, although the ratio
was also high in CVH as well as early PBC. The increased ratio
of IFNc/Foxp3 may be related to the active inflammation
irrespective of aetiology. Taken together, results of the present
study suggest that Foxp3+Tregs may be involved in the
maintenance of chronic inflammation in PBC and CVH livers
and that Foxp3+Tregs may not be related to the pathogenesis of
PBC. In contrast to the present study, Lan et al recently reported
the relative decrease of Foxp3+Tregs in PBC and suggested that
Foxp3+Tregs may play role in the loss of tolerance in PBC.17
However, their functional studies did not reveal a global PBC
Tregs defect.17 Further studies are needed to clarify the real
function and target(s) of Tregs infiltrating to portal tracts in
PBC.
Similar to our present study, several recent reports have
demonstrated the increased infiltration of Foxp3+Tregs in
damaged organs or target tissues in autoimmune diseases.32 33
These reports suggested that suppressor cells migrate to and/or
multiply at the sites of inflammation as part of the immune
Figure 1 Degrees of regulatory T cells (Tregs) expressing Forkhead box
P3 (Foxp3+Tregs) infiltration in portal tracts depending on three types
portal tract histopathology in primary biliary cirrhosis (PBC) and control
livers. Foxp3+Tregs infiltrated more extensively into portal tracts with
chronic inflammation (types A and B) compared with non-inflamed portal
tracts (type C) in PBC and chronic viral hepatitis (CVH). Foxp3+Tregs
infiltrated more extensively into portal tracts with (chronic non-suppurative
destructive cholangitis (CNSDC) (type A) in PBC compared with portal
tracts without CNSDC in PBC and CVH (p,0.05). A, chronically inflamed
portal tracts containing CNSDC; B, chronically inflamed portal tracts
without CNSDC; C, non-inflamed portal tracts. Extent of infiltration: 0,
portal tract containing ,2 Foxp3-expressing cells; 1, portal tract
containing 2–5 Foxp3-expressing cells; 2, portal tract containing 6–10
Foxp3-expressing cells; 3, portal tract containing .10 Foxp3-expressing
cells. NL, normal liver. *p,0.05.
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Figure 2 Distribution of regulatory T cells (Tregs) expressing Forkhead box P3 (Foxp3+Tregs) in primary biliary cirrhosis (PBC) and control livers. (A) There
were no or few Foxp3+Tregs in portal tracts and hepatic parenchyma in normal livers. Arrow indicates the small bile duct. Normal liver,6200. (B) Tregs
infiltrated around follicle-like accumulation of lymphoid cells (*) was frequently observed in portal tracts. Arrow indicates a small bile duct. CVH, type C.
6200. (C) Foxp3+Tregs showing positive nuclear staining infiltrated extensively into portal tracts with chronic non-suppurative destructive cholangitis
(CNSDC) in PBC. Tregs infiltrated occasionally into the biliary epithelial layer at the site of CNSDC (arrow). PBC liver, stage 1.6400. (D) Accumulation of
Tregs was noted at the interface of portal tracts. Tregs infiltrated occasionally into the biliary epithelial layer at the site of CNSDC (arrow). PBC liver, stage 1,
6400.
Figure 3 Semi-quantitative reverse transcriptase (RT)-PCR for Foxp3, IL-10 and TGFb mRNA in primary biliary cirrhosis (PBC) and control livers.
(A) Representative gel image of Foxp3 and IL-10 mRNA expression. Foxp3 and IL-10 mRNA were detected in PBC and chronic viral hepatitis (CVH) livers,
but were not detected in normal livers (NL). (B–D) Semi-quantitative levels of Foxp3 (B), IL-10 (C) and TGFb (D) mRNA expression in PBC and control livers.
The levels of Foxp3, IL-10 and TGFb mRNA were significantly increased in PBC livers, when compared with normal livers. Gel images were evaluated using
NIH image and the expression was normalised as a ratio using human G3PDH as a housekeeping gene. Data expressed as mean (SD). *p,0.05 vs normal
liver; **p,0.05 vs CVH liver.
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response to combat injurious inflammation,33 and these Tregs
may be unable to down-modulate the autoimmune response.32
Recently, naturally-occurring Tregs were reported not to
contribute to the development of airway tolerance induced by
orally administered antigen.34 Taken together, Foxp3+Tregs
may not cover all types of immune tolerance and Foxp3+Tregs
may not be related to the pathogenesis of some autoimmune
diseases including PBC.
In conclusion, in PBC and CVH livers, the extent of Tregs
infiltration in portal tracts was in parallel with the extent of
chronic inflammation, irrespective of disease, and Tregs
infiltration was extensive in portal tracts with CNSDC. This
report examining naturally occurring Tregs failed to support the
interesting idea that Tregs failure is related to the development
of CNSDC via loss of self-tolerance in PBC.
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A
new staging system has performed well in an initial validation study, signalling a big step
forward in the care and treatment of patients at risk of gastric cancer.
The system, devised by an international group of gastroenterologists and pathologists
(OLGA), and based on a synthesis of the extent and location of histological atrophy of the
gastric mucosa, successfully distinguished between patients with gastric cancer and those with
benign conditions. Cancerous invasive or non-invasive lesions, present in 21/439 patients,
clustered exclusively in OLGA stages III/IV whereas benign conditions like duodenal and gastric
ulcers clustered in stages 0–II.
OLGA stage should in future be stated at the end of histological reports, plus Helicobacter pylori
status (positive/negative/suspected) or other possible cause or important risk factor for gastric
cancer.
The prospective cross sectional study was carried out during one year on consecutive
outpatients with dyspepsia at a gastroenterology clinic of one hospital in Padua, Italy. Each had
biopsy specimens taken of lesions in the upper gastrointestinal tract.
Modelled on a successful staging system for reporting on hepatitis, the OLGA system was
devised to replace existing systems for reporting chronic atrophic gastritis that are inconsistently
used and do not provide useful information on disease outcome. It relies on standardised biopsy
sampling and histological scoring of atrophic disease to provide an index of mucosal atrophy,
representing disease progression, combined with mapping of the atrophy within the
gastrointestinal tract.
Multicentre trials are now needed to confirm these results for other populations.
m Rugge M, et al. Gut 2007;56:631–636.
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